These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25658035)

  • 1. Molecular dynamics study of the recognition of dimethylated CpG sites by MBD1 protein.
    Bianchi C; Zangi R
    J Chem Inf Model; 2015 Mar; 55(3):636-44. PubMed ID: 25658035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Base-flipping propensities of unmethylated, hemimethylated, and fully methylated CpG sites.
    Bianchi C; Zangi R
    J Phys Chem B; 2013 Feb; 117(8):2348-58. PubMed ID: 23363335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of transcriptional regulation by methyl-CpG binding protein MBD1.
    Fujita N; Shimotake N; Ohki I; Chiba T; Saya H; Shirakawa M; Nakao M
    Mol Cell Biol; 2000 Jul; 20(14):5107-18. PubMed ID: 10866667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG dinucleotide positioning patterns determine the binding affinity of methyl-binding domain to nucleosomes.
    Mendonca A; Sanchez OF; Liu W; Li Z; Yuan C
    Biochim Biophys Acta Gene Regul Mech; 2017 Jun; 1860(6):713-720. PubMed ID: 28377300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards an understanding of DNA recognition by the methyl-CpG binding domain 1.
    Rauch C; Trieb M; Wibowo FR; Wellenzohn B; Mayer E; Liedl KR
    J Biomol Struct Dyn; 2005 Jun; 22(6):695-706. PubMed ID: 15842174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the ability of MBD domains to bind methyl-CG and TG sites in DNA.
    Liu K; Xu C; Lei M; Yang A; Loppnau P; Hughes TR; Min J
    J Biol Chem; 2018 May; 293(19):7344-7354. PubMed ID: 29567833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of CpG methylation on DNA binding protein: molecular dynamics simulations of the homeodomain PITX2 bound to the methylated DNA.
    Yang SY; Yang XL; Yao LF; Wang HB; Sun CK
    J Mol Graph Model; 2011 Jun; 29(7):920-7. PubMed ID: 21498098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional specificity of CpG DNA-binding CXXC domains in mixed lineage leukemia.
    Risner LE; Kuntimaddi A; Lokken AA; Achille NJ; Birch NW; Schoenfelt K; Bushweller JH; Zeleznik-Le NJ
    J Biol Chem; 2013 Oct; 288(41):29901-10. PubMed ID: 23990460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2).
    Valinluck V; Tsai HH; Rogstad DK; Burdzy A; Bird A; Sowers LC
    Nucleic Acids Res; 2004; 32(14):4100-8. PubMed ID: 15302911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The solution structure of the domain from MeCP2 that binds to methylated DNA.
    Wakefield RI; Smith BO; Nan X; Free A; Soteriou A; Uhrin D; Bird AP; Barlow PN
    J Mol Biol; 1999 Sep; 291(5):1055-65. PubMed ID: 10518942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recruitment of MBD1 to target genes requires sequence-specific interaction of the MBD domain with methylated DNA.
    Clouaire T; de Las Heras JI; Merusi C; Stancheva I
    Nucleic Acids Res; 2010 Aug; 38(14):4620-34. PubMed ID: 20378711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA.
    Ohki I; Shimotake N; Fujita N; Jee J; Ikegami T; Nakao M; Shirakawa M
    Cell; 2001 May; 105(4):487-97. PubMed ID: 11371345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UHRF1 discriminates against binding to fully-methylated CpG-Sites by steric repulsion.
    Bianchi C; Zangi R
    Biophys Chem; 2013 Jan; 171():38-45. PubMed ID: 23245651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CH···O Hydrogen Bonds Mediate Highly Specific Recognition of Methylated CpG Sites by the Zinc Finger Protein Kaiso.
    Nikolova EN; Stanfield RL; Dyson HJ; Wright PE
    Biochemistry; 2018 Apr; 57(14):2109-2120. PubMed ID: 29546986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of the methyl-CpG-binding domain of the methylation-dependent transcriptional repressor MBD1.
    Ohki I; Shimotake N; Fujita N; Nakao M; Shirakawa M
    EMBO J; 1999 Dec; 18(23):6653-61. PubMed ID: 10581239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
    Wischnewski F; Friese O; Pantel K; Schwarzenbach H
    Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation-mediated transcriptional silencing in euchromatin by methyl-CpG binding protein MBD1 isoforms.
    Fujita N; Takebayashi S; Okumura K; Kudo S; Chiba T; Saya H; Nakao M
    Mol Cell Biol; 1999 Sep; 19(9):6415-26. PubMed ID: 10454587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An epigenetic regulator: methyl-CpG-binding domain protein 1 (MBD1).
    Li L; Chen BF; Chan WY
    Int J Mol Sci; 2015 Mar; 16(3):5125-40. PubMed ID: 25751725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual base-flipping of cytosines in a CpG dinucleotide sequence.
    Bianchi C; Zangi R
    Biophys Chem; 2014; 187-188():14-22. PubMed ID: 24469333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methyl-CpG-binding domain proteins: readers of the epigenome.
    Du Q; Luu PL; Stirzaker C; Clark SJ
    Epigenomics; 2015; 7(6):1051-73. PubMed ID: 25927341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.